These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4257977)

  • 1. [Characterization of streptokinase-induced activator].
    Heimburger N; Schwick HG
    Arzneimittelforschung; 1971 Oct; 21(10):1439-43. PubMed ID: 4257977
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 3. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 4. [Further studies on thrombolysis with streptokinase: effect of streptokinase on plasmin inhibitors, aging changes in thrombi].
    Gottlob R; Blümel G
    Klin Med Osterr Z Wiss Prakt Med; 1967; 22(5):233-4. PubMed ID: 4234347
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of thrombin, plasmin and plasminogen activation by amidino compounds.
    Geratz JD
    Thromb Diath Haemorrh; 1970 Jun; 23(3):486-99. PubMed ID: 4247029
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of proteolytic and fibrinolytic factors in the human prostate.
    Nijs M; Brassinne C; Coune A; Tagnon HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(3):481-98. PubMed ID: 4104828
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of streptokinase and human plasminogen. IV. Further gel electrophoretic studies on the combination of streptokinase with human plasminogen or human plasmin.
    De Renzo EC; Boggiano E; Barg WF; Buck FF
    J Biol Chem; 1967 May; 242(10):2428-34. PubMed ID: 4226006
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
    Lukasiewicz H; Niewiarowski S
    Thromb Diath Haemorrh; 1968 Jul; 19(3):584-92. PubMed ID: 4236825
    [No Abstract]   [Full Text] [Related]  

  • 9. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.
    Thorsen S; Kok P; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):325-40. PubMed ID: 4450189
    [No Abstract]   [Full Text] [Related]  

  • 11. [The determination of the proactivator of the fibrinolytic system with a quantitative caseinolytic method].
    Spöttl F
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):393-403. PubMed ID: 4232161
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activation and inhibition of buffy crust fibrinolysis in vitro].
    Harms D
    Gegenbaurs Morphol Jahrb; 1968; 111(3):488-92. PubMed ID: 4232858
    [No Abstract]   [Full Text] [Related]  

  • 13. A sensitive fluorometric assay for plasminogen, plasmin, and streptokinase.
    Bell PH; Dziobkowski CT; Englert ME
    Anal Biochem; 1974 Sep; 61(1):200-8. PubMed ID: 4277983
    [No Abstract]   [Full Text] [Related]  

  • 14. The sensitivity of rabbit plasminogen to streptokinase in circulating blood.
    Janda R
    Folia Histochem Cytochem (Krakow); 1973; 11(3):235-43. PubMed ID: 4778383
    [No Abstract]   [Full Text] [Related]  

  • 15. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
    Johnson AJ; Tse A; Skoza L
    Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioimmunoassay of human plasminogen and plasmin.
    Rabiner SF; Goldfine ID; Hart A; Summaria L; Robbins KC
    J Lab Clin Med; 1969 Aug; 74(2):265-73. PubMed ID: 4240543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro enhancement of AA-degrading activity in human plasma with the plasminogen activator streptokinase.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Dec; 14(6):637-41. PubMed ID: 6210954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of fibrinogen and proteolysis in surface activation. A study with the recording ellipsometer.
    Vroman L; Adams AL
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):510-24. PubMed ID: 4232164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.